February 10, 2024
1 min watch
Save
VIDEO: Upadacitinib could produce ‘rapid’ improvement in atopic dermatitis
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Raj Chovatiya, MD, PhD, discussed research into the Janus kinase inhibitor upadacitinib from the Maui Derm 2024 meeting, examining data into its use in treating atopic dermatitis.
Chovatiya, assistant professor of dermatology at Northwestern University Feinberg School of Medicine, discussed a 5-year safety update into upadacitinib in atopic dermatitis, as well as promising data regarding itch and sleep.
“(The data suggests) that you may actually have pretty rapid improvement as of really the first night all the way up to 1 month,” Chovatiya said.